Naveris, Inc. | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Video & Media
Keywords & Focus Areas
Naveris, Inc.
Overview
Naveris, Inc. is a precision oncology diagnostics company founded in 2017, specializing in liquid biopsy assays to enable early detection and management of viral-associated cancers, particularly those linked to Human Papilloma Virus (HPV). Headquartered in Waltham, Massachusetts, with additional facilities in Durham, North Carolina, the organization operates CLIA-certified laboratories accredited by recognized health authorities.
The primary offering, NavDx®, is a blood-based liquid biopsy test that utilizes digital droplet PCR to detect HPV particles in plasma cell-free DNA for early cancer detection and monitoring of recurrence in head and neck cancer patients. Naveris also supports underserved populations through Molecular Residual Disease (MRD) surveillance and plans to expand services to anal cancer. With a commitment to continuous diagnostic innovation, the company enhances clinical care through real-world validation and ongoing research initiatives.
Basic Information
| Industry | research |
|---|---|
| Founded | 2017 |
| Revenue | 2M |
| Headquarters | 21 Hickory Drive, Suite 600, Waltham, Massachusetts 02451, United States |
Contact Details
- Phone: +1 833-628-3747
- Website: naveris.com
- LinkedIn: linkedin.com/company/naveris
Key Focus Areas & Initiatives
- Liquid biopsies for early detection
- Drug discovery
- Validation
- Patient drug selection
- Biotechnology research
- Proprietary technology
- Predictive analytics
- HPV-related cancer diagnostics
- Clinical validation studies
- Biomarker analysis
- Molecular diagnostics
- Cancer surveillance
- Predictive values
- Molecular residual disease monitoring
- Non-invasive blood testing
- HPV DNA quantification
- HPV-driven cancer detection
- Oncology monitoring
- Blood tests for cancer recurrence
- HPV DNA analysis
- Cancer recurrence monitoring
- Healthcare technology innovation
- Clinical validation and utility
- Head and neck cancer detection
- Healthcare services
- Sensitivity and specificity assessment
- Circulating tumor DNA detection
- Recurrence prediction
- Oncology diagnostics
- HPV-associated cancer surveillance
- Oropharyngeal cancer diagnosis
- Real-time cancer monitoring
- Real-world validation
Technologies Used
- Apache
- GoDaddy Hosting
- Google Font API
- Google Tag Manager
- Microsoft Office 365
- Mobile Friendly
- Pantheon
- Remote
- Salesforce
- Slack
- Vimeo
- WordPress.org
Community
